Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile-Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence. | J Med Chem | 2023 | 36581322 | PubTator, text mining | PubMed |
| Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5-mediated p53 degradation blockage. | Clin Transl Med | 2023 | 36578176 | PubTator, text mining | PubMed |
| Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface. | Neural Regen Res | 2023 | 36571340 | PubTator, text mining | PubMed |
| m6A RNA methylation regulators predict prognosis and indicate characteristics of tumour microenvironment infiltration in acute myeloid leukaemia. | Epigenetics | 2023 | 36567510 | PubTator, text mining | PubMed |
| Analysis approaches for the identification and prediction of N6-methyladenosine sites. | Epigenetics | 2023 | 36562485 | PubTator, text mining | PubMed |
| Anti-cancer effect of entacaponeon esophageal cancer cells via apoptosis induction and cell cycle modulation. | Cancer Rep (Hoboken) | 2023 | 36534072 | PubTator, text mining | PubMed |
| The cap epitranscriptome: Early directions to a complex life as mRNA. | Bioessays | 2023 | 36529693 | PubTator, text mining | PubMed |
| Antibody-free photoelectrochemical strategy for simultaneous detection of methylated RNA, METTL3/METTL14 protein and MazF protein based on enhanced photoactivity of MoSe2-BiOI nanocomposite. | Biosens Bioelectron | 2023 | 36529055 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma. | J Clin Lab Anal | 2023 | 36525280 | PubTator, text mining | PubMed |
| METTL3 and METTL14-mediated N6-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis. | Reprod Biomed Online | 2023 | 36517319 | PubTator, text mining | PubMed |
| Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T-Cell Acute Lymphoblastic Leukemia. | Adv Sci (Weinh) | 2023 | 36478193 | PubTator, text mining | PubMed |
| RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R. | Thorac Cancer | 2023 | 36448247 | PubTator, text mining | PubMed |
| Expression of m6A Methylation Regulator in Osteoarthritis and Its Prognostic Markers. | Cartilage | 2023 | 36443992 | PubTator, text mining | PubMed |
| m6A-SAC-seq for quantitative whole transcriptome m6A profiling. | Nat Protoc | 2023 | 36434097 | PubTator, text mining | PubMed |
| KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification. | Cancer Med | 2023 | 36420693 | PubTator, text mining | PubMed |
| Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells. | Transl Oncol | 2023 | 36413861 | PubTator, text mining | PubMed |
| Real-World Practice of Gastric Cancer Prevention and Screening Calls for Practical Prediction Models. | Clin Transl Gastroenterol | 2023 | 36413795 | PubTator, text mining | PubMed |
| Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 36406319 | PubTator, text mining | PubMed |
| Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization. | Bioact Mater | 2023 | 36406251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=73